Pfizer, Protalix Tie Up For Sales Of Gaucher's Drug In Brazil Disappointing
This article was originally published in PharmAsia News
Executive Summary
Not all drug makers in major emerging markets such as Brazil profit heavily by partnering with major global drug makers, and Brazil's Protalix Biotherapeutics's tie up with Pfizer for a Gaucher's disease drug Elelyso (taliglucerase) may be an example.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.